Scaling the Cure: Navigating Demand and Capacity in Viral Vector Production
The Commercialization Surge in Cell and Gene Therapy With the approval of several landmark gene therapies, the focus has shifted from clinical feasibility to commercial scalability. Lentiviral vectors are the preferred choice for many researchers due to their ability to transduce both dividing and non-dividing cells. However, scaling a process that worked in a 10-liter lab flask to a 500-liter...
0 Commenti 0 condivisioni 22 Views 0 Anteprima